MARKET

ASND

ASND

Ascendis Pharma
NASDAQ
135.49
-1.03
-0.75%
Opening 15:51 07/19 EDT
OPEN
137.25
PREV CLOSE
136.52
HIGH
137.25
LOW
132.84
VOLUME
371.77K
TURNOVER
0
52 WEEK HIGH
161.00
52 WEEK LOW
85.29
MARKET CAP
7.89B
P/E (TTM)
-14.1358
1D
5D
1M
3M
1Y
5Y
1D
$1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 10 years by 43.24%. The company has an average annual return of 54.04% on an annualized basis. If an investor bought $1000 of ASND stock 10 years ago, it would be worth $74,821.
Benzinga · 1d ago
Artisan International Fund Q2 2024 Commentary
With inflation slowing in many countries, equity markets saw modest returns in Q2. Stocks in Asia ex-Japan and North America performed particularly well. Growth outperformed value stocks in most regions. The portfolio fell short of the MSCI EAFE Index and MSCi All Country World ex USA Index.
Seeking Alpha · 3d ago
Morgan Stanley Remains a Hold on Ascendis Pharma (ASND)
TipRanks · 4d ago
Weekly Report: what happened at ASND last week (0708-0712)?
Weekly Report · 4d ago
Wells Fargo Keeps Their Buy Rating on Ascendis Pharma (ASND)
TipRanks · 07/11 10:49
Ascendis Pharma Announces Capital and Warrant Updates
TipRanks · 07/10 20:27
Validea Detailed Fundamental Analysis - ASND
NASDAQ · 07/08 18:10
Morgan Stanley Reaffirms Their Hold Rating on Ascendis Pharma (ASND)
TipRanks · 07/08 12:25
More
About ASND
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Webull offers Ascendis Pharma A/S (ADR) stock information, including NASDAQ: ASND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASND stock methods without spending real money on the virtual paper trading platform.